A new awareness of vitiligo and new treatments coming to market is providing a multitude of options for treating the disease, said Brett King, MD, PhD, associate professor of dermatology, Yale School ...

Neil Minkoff; Natasha Mesinkovska, MD; and Brett King, MD, PhD discuss the diagnosis and disease assessment in alopecia areata along with clinical considerations. 259 Prospect Plains Rd, Bldg H ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. NEW ORLEANS — In this Healio exclusive video, Brett King ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — In this Healio exclusive video, Brett King, MD, PhD, discusses data indicating that down titration ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. NEW ORLEANS — In this Healio exclusive video, Brett King ...

Prior to this first therapy for repigmentation being approved, the only approved therapy was a depigmenting agent, which is usually the opposite of what providers are trying to accomplish with ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — In this Healio video perspective here at the American Academy of Dermatology, Brett King, MD, PhD, ...

The results indicate improved response rates and hair growth among trial participants, said Brett King, MD, PhD, an associate professor of dermatology at the Yale University School of Medicine in New ...

Vitiligo’s effects on clinical burden and patient quality of life are addressed by Brett King, MD, PhD, and David Rosmarin, MD. Jeffrey D. Dunn, PharmD, MBA: Dr King, what are the clinical ...

Key opinion leaders discuss how diagnosing vitiligo can lead to myriad treatment options. Jeffrey D. Dunn, PharmD, MBA: Is diagnosing vitiligo pretty straightforward? Are there examples where it isn’t ...

Please provide your email address to receive an email when new articles are posted on . Higher doses of a novel Janus kinase inhibitor were associated with improved response over 24 weeks in a cohort ...